- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 143.86M sh |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $216M |
| Cash And Equivalents | Q1 2026 · Jan 31, 2026 | $320.36M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $394.89M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $727.94M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.12B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.43B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.68B |
| Shares Diluted | Q1 2026 · Jan 31, 2026 | 140.45M sh |
| Shares Diluted | Q1 2026 · Jan 31, 2026 | 140.45M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 136.9M sh |
| Dividends Paid | Q1 2026 · Jan 31, 2026 | $991K |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $88.21M |
| Operating Cash Flow | Q1 2026 · Jan 31, 2026 | −$39.35M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $3.83M |
| Eps Diluted | Q1 2026 · Jan 31, 2026 | −$0.05 |
| Eps Diluted | Q1 2026 · Jan 31, 2026 | −$0.05 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.10 |
| Eps Basic | Q1 2026 · Jan 31, 2026 | −$0.05 |
| Eps Basic | Q1 2026 · Jan 31, 2026 | −$0.05 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.10 |
| Sga Expense | Q1 2026 · Jan 31, 2026 | $3.3M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $8.18M |
| Net Income | Q1 2026 · Jan 31, 2026 | −$7.74M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$13.92M |
| Operating Income | Q1 2026 · Jan 31, 2026 | $2.03M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $9.74M |
| Revenue | Q1 2026 · Jan 31, 2026 | $6.16M |
| Revenue | Q1 2026 · Jan 31, 2026 | $6.16M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $22.88M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $457.32M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $361.85M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $256K |